Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
10 hedge funds and large institutions have $1.34M invested in Aptose Biosciences, Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.
23% less funds holding
Funds holding: 13 → 10 (-3)
46% less capital invested
Capital invested by funds: $2.48M → $1.34M (-$1.14M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$6.74K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$1.34M |
| 2 |
Jane Street
New York
|
-$14K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$11.1K |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$3.37K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $1.22M | – | – | – |
|
|
2
Renaissance Technologies
New York
| $39K | +$6.74K | +14 | +25% |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $36K | -$2.41K | -5 | -7% |
|
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $23K | -$11.1K | -23 | -36% |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $11.6K | – | – | – |
|
6
Morgan Stanley
New York
| $7K | – | – | – |
|
|
7
Parallax Volatility Advisers
San Francisco,
California
| $4K | -$3.37K | -7 | -50% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $4K | +$2.89K | +6 | New |
|
9
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
10
Franklin Resources
San Mateo,
California
| – | -$1.34M | -2,941 | Closed |
|
|
11
Jane Street
New York
| – | -$14K | -30 | Closed |
|
12
Creative Planning
Overland Park,
Kansas
| – | -$1K | -2 | Closed |
|
13
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$963 | -2 | -67% |
|
APTO Hedge Fund Activity: Q2 2017 in Review
10 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q2 2017, worth a combined $1.34M — down 46% from $2.48M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of APTO and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $6.74K. The largest seller was Franklin Resources, exiting entirely with an estimated $1.34M sold.
- 10 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q2 2017, down from 13 in Q1 2017.
- Funds reported $1.34M of Aptose Biosciences, Inc. stock for Q2 2017, down 46% quarter-over-quarter.
- 1 fund opened new Aptose Biosciences, Inc. positions in Q2 2017 and 4 closed out, a net change of -3 holders.
- The largest Aptose Biosciences, Inc. buyer in Q2 2017 was Renaissance Technologies, an estimated $6.74K added.
- The largest Aptose Biosciences, Inc. seller in Q2 2017 was Franklin Resources, an estimated $1.34M sold.
Based on aggregated 13F filings for Q2 2017.